These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9916621)

  • 1. Cytokines in GvH and GvL.
    Holler E; Kolb HJ; Eissner G; Wilmanns W
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S3-6. PubMed ID: 9916621
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease: a surge of developments.
    Riddell SR; Appelbaum FR
    PLoS Med; 2007 Jul; 4(7):e198. PubMed ID: 17622190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
    Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
    J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
    Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
    Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.
    Dickinson AM; Wang XN; Sviland L; Vyth-Dreese FA; Jackson GH; Schumacher TN; Haanen JB; Mutis T; Goulmy E
    Nat Med; 2002 Apr; 8(4):410-4. PubMed ID: 11927949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic cell transplantation as immunotherapy.
    Appelbaum FR
    Nature; 2001 May; 411(6835):385-9. PubMed ID: 11357147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting beneficial alloreactive T cells.
    Barber LD; Madrigal JA
    Vox Sang; 2006 Jul; 91(1):20-7. PubMed ID: 16756597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloblastic leukaemia: graft-versus-host and graft-versus-leukaemia responses to autologous IL-2 activated lymphocytes in rapid and slow disease.
    Boughton BJ; Simpson AW
    Cytokines Cell Mol Ther; 1999 Mar; 5(1):1-6. PubMed ID: 10390074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolytic pathways in haematopoietic stem-cell transplantation.
    van den Brink MR; Burakoff SJ
    Nat Rev Immunol; 2002 Apr; 2(4):273-81. PubMed ID: 12001998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
    Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
    Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease.
    Cooke KR; Olkiewicz K; Erickson N; Ferrara JL
    J Endotoxin Res; 2002; 8(6):441-8. PubMed ID: 12697087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From tumor-host to feto-maternal relationship. Immunological studies.
    Pasqualini CD; Piazzon I; Matusevich M; Déroche A
    Prog Clin Biol Res; 1982; 87():277-87. PubMed ID: 6981118
    [No Abstract]   [Full Text] [Related]  

  • 17. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease.
    Chao NJ
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):215-23. PubMed ID: 15077220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Graft vs host reaction and graft vs host diseases].
    Sakagami K; Orita K
    Nihon Rinsho; 1985 Jan; 43(1):97-103. PubMed ID: 3886972
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer.
    Schirrmacher V; Beckhove P; Choi C; Griesbach A; Mahnke Y
    Int J Oncol; 2005 Oct; 27(4):1141-9. PubMed ID: 16142333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease.
    Sackstein R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):2-8. PubMed ID: 16399577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.